Clostridium difficile has been recognized as a cause of nosocomial diarrhea and pseudomembranous colitis. The enteropathogenicity is associated with the production of enterotoxin A (308 kDa) and cytotoxin B (270 kDa) (6, 14) . Toxin A is an extremely potent enterotoxin and has been regarded as the primary virulence factor (27, 30) . The effect of cytotoxin B depends on the tissue damage caused by toxin A, suggesting that both toxins work synergistically (31) .
Toxin A (tcdA) and B (tcdB) genes are located on a pathogenicity island of 19.6 kb also encompassing three other small open reading frames (20) . Nontoxigenic, and therefore nonpathogenic, strains of C. difficile contain a 127-bp sequence at this locus (19) . The sequence similarity and the position on the island suggests that the tcdA and tcdB genes are the result of gene duplication (15) .
Clinical isolates from patients with nosocomial diarrhea or pseudomembranous colitis usually produce both toxin A and B, but an increasing number of reports mention severe infections and outbreaks due to toxin A-negative, toxin B-positive (A Ϫ /B ϩ ) strains (2, 3, 21, 24, 26, 28) . Two types of toxin A Ϫ /B ϩ strains have been identified. The first type is characterized by a large deletion of 5.6 kb in the tcdA gene. The representative strain (8864) causes fluid secretion in rabbit intestinal loops, and it has been suggested that the production of a variant toxin is associated with its enteropathogenicity (8, 29) . This variant toxin seems more potent than toxin B and is more similar to Clostridium sordellii lethal toxin (37) . The second type is more frequently isolated from human fecal samples, contains a small deletion of 1.8 kb within the repetitive regions of the tcdA gene, and belongs to serogroup F (13) . PCR ribotyping has appeared to be a robust genotyping method. Results can be used for interlab comparison and for the generation of libraries. However, different primers have been proposed, which raises the question of which are most suited for future studies on the epidemiology of C. difficile. The PCR ribotyping by O'Neill as described by Stubbs et al. contains a large library which is used worldwide (38) . This method has been modified with primers presumed to be more specific for C. difficile by Bidet et al. (7) . Pulsed-field gel electrophoresis (PFGE) is considered the "gold standard" for genotyping, but due to intensive DNA degradation in some strains, other techniques are preferred. Amplified fragment length polymorphism (AFLP) has been applied for molecular typing of a variety of bacterial species (1) . Recently, AFLP analysis of C. difficile strains showed that its discriminatory power was similar to that of PFGE when tested on 30 clinical isolates. However, reference strains encompassing different reference strains and toxin A Ϫ /B ϩ strains were not included in the analysis (25) . 
MATERIALS AND METHODS
Bacterial strains and culture conditions. Reference strains of C. difficile encompassing 30 known serogroups were included in this study as control strains: A, A1 to A11, A13 to A17, B, C, E6, F, G, H, I, K, S1 to S4, and X (supplied by M. Delmee, University of Louvain, Brussels, Belgium). Clinical isolates (n ϭ 50) were obtained from 7 different countries (Table 1 ). The biochemical identification of the strains was confirmed on the basis of the morphology after Gram staining, growth on CDMN agar (C. difficile agar with moxalactam, norfloxacin, and cystein) (4), and a positive aminopeptidase reaction (18) . Strains were stored at Ϫ80°C in glycerol broth and subcultured onto sheep blood agar medium in an anaerobic atmosphere for usage for 48 h. DNA isolation. DNA was extracted from bacterial cultures on solid media by using QIAamp DNA isolation columns (Qiagen, Hilden, Germany) according to the manufacturer's recommendations, including a preceding 10-min incubation at 55°C with proteinase K (Qiagen). The final volume of the DNA extracts was 200 l.
PCR ribotyping. (i) O'Neill method. The method described by Stubbs et al. (38) was followed. The primers used (PRO primers) for amplification are specified in Table 2 . Briefly, amplification reactions were performed in 100-l final volume containing 50 pmol of each primer, 2 U of Taq DNA polymerase (Pharmacia), 2.25 mM MgCl 2 , and 10 l of DNA. The final products were separated by electrophoresis on 3% Metaphor agarose (FMC Bioproducts, Rockland, Maine) for 3 h at 200 V. Amplified fragments were visualized by staining the gel for 20 min in a 1-g/ml ethidium bromide solution. For normalization, a molecular size standard (100 bp; Advanced Biotechnologies, Epsom, United Kingdom) was added every five lanes.
(ii) Bidet method. The method as described by Bidet et al. (7) was followed. The primers used for amplification (PRB primers) are specified in Table 2 . Briefly, the amplification reactions were performed in a 50-l final volume containing 25 l of HotStar Taq master mix (Qiagen), 10 pmol of each primer, and 5 l of DNA. After an initial enzyme activation step of 15 min at 95°C, the protocol consisted of 35 cycles of 1 min at 94°C for denaturation, 1 min at 57°C for annealing, and 1 min at 72°C for elongation. The amplified products were separated by electrophoresis on 1.5% agarose for 3 h at 85 V.
AFLP. The conditions for AFLP were as previously described by Klaassen et al. (25) . Enzymes EcoRI and MseI were used for restriction. For amplification, the labeled EcoRI primer with 6-carboxy-fluorescein was used, and for selective amplification, the MseI primer contained a G residue as the selective nucleotide.
Analysis of fingerprints. The results of fingerprinting by the three genotyping methods were stored as tagged image file format files and imported into the BioNumerics software (Applied Maths, Kortrijk, Belgium) for further analysis, with the Pearson product moment correlation coefficient and the unweighted pair group method with arithmetic mean used for clustering. The clustering level of two duplicates was used to delineate different types. Genetic identification of clindamycin resistance. Clindamycin resistance was tested by a PCR targeting the erm(B) gene, which codes for macrolide-lincosamide-streptogramin B (MLS) resistance, as described previously by Sutcliffe et al. (39) for several pathogenic bacterial species. The primers used (282BacS and 283BacAS) ( Table 2 ) also reacted with C. difficile according to an alignment in BLAST. The sequence of C. difficile erm(B) is more than 97% identical with those of erm(B) genes from other bacterial species (16) . Clindamycin-resistant strains were defined as strains with a 639-bp amplicon size.
Genetic identification of tcdA and tcdB profiles. All strains were tested for the presence of genes tcdA and tcdB. For detection of the tcdA gene, primers NKV011 and NK9 (Table 2) were used as described by Kato et al. (23) . Toxin A ϩ strains showed a 2,535-bp amplicon size, whereas toxin A Ϫ strains were defined as strains with a deletion in the tcdA gene of 1.7 or 1.8 kb. The tcdB profile was verified with primers NK104 and NK105 (Table 2) as described previously (24) . The presence of a 204-bp fragment was considered indicative for the presence of the tcdB gene. The amplified products were analyzed by separation by agarose gel electrophoresis. Isolates with the 1.8-kb deletion in the tcdA gene and with a tcdB-positive PCR were included in the toxin A Ϫ /B ϩ group. Isolates with other toxin profiles were included in the so-called unrelated group, since no relation with the toxin A Ϫ isolates existed.
RESULTS
C. difficile reference strains. Twenty-one of 30 reference strains were positive for the tcdA and tcdB genes ( Table 3) . Strains of serogroups A7, A9, A10, A11, and B I, and X did not contain genes for the toxins, whereas those of serogroups F and S3 harbored only the tcdB gene and a variant tcdA gene. The reference strain of serogroup F had the 1.8-kb deletion in the tcdA amplicon, whereas the strain of serogroup S3 had a deletion of approximately 0.8 kb.
By AFLP, 29 types were distinguished among the 30 reference strains ( Fig. 1; Table 3 ). Strains representing serogroups A7 and A11 were indistinguishable by AFLP. PCR ribotyping by the Bidet method distinguished 25 genotypes in this group. Strains of serogroups A9 and A10 and of serogroups A8 and S1 were indistinguishable by this PCR ribotyping but could be differentiated by PCR ribotyping by the O'Neill method. The latter PCR ribotyping method was able to identify 26 genotypes among the reference strains. Both PCR ribotyping techniques were not able to separate the reference strain of serogroup H from that of serogroup K and the strain of serogroup A14 from that of serogroup S4 ( Table 3) . As was the case with AFLP, strains of serogroup A7 and A11 could not be differentiated by the two PCR ribotyping methods.
Clinical isolates of C. difficile. In the group of 50 clinical isolates, one sample (R11092) contained two variant strains. One variant was positive for the tcdA gene, and the second strain contained the 1.8-kb deletion. Both strains were used for analysis. A total of 39 isolates contained the deletion of 1.7 or 1.8 kb in the tcdA gene and were positive for the tcdB gene ( isolates and in 2 of the 12 unrelated isolates (P Ͻ 0.001, chi-square test) ( Table 4) .
DISCUSSION
In this study, the discriminatory power and typeability of AFLP and two different PCR ribotyping methods were compared by using 30 reference strains and 51 clinical isolates of C. difficile. The strains were also characterized for their toxin profiles and susceptibility to clindamycin. AFLP had the highest discriminatory power for differentiation of the reference strains. Concerning the 39 toxin A Ϫ /B ϩ isolates and 12 unrelated strains, the typeability was 100% for all three genotyping methods with a similar discriminatory power.
The AFLP method uses restriction, ligation, and selective amplification on the whole genome. Differentiation can be made due to variation per type in restriction site mutations, mutations in the sequences adjacent to the restriction sites and complementary to the selective primer extensions, and insertions and deletions within the amplified fragments. AFLP for C. difficile has been compared with PFGE by Klaassen et al. (25) . Previously, PFGE was found to be more discriminatory than random amplified polymorphic DNA and PCR ribotyping (41) . The study by Klaassen also showed that the typeability of AFLP was better than that of PFGE, especially for C. difficile isolates for which PFGE showed DNA degradation. In addition, AFLP was considered faster and easier to perform on small quantities of DNA. The reproducibility of AFLP was found to be similar to that of PFGE (25) , which has a much higher reproducibility than restriction enzyme analysis (REA), arbitrary primed PCR, and random amplified polymorphic DNA (10) . PFGE data are readily exchangeable between laboratories, and it might be expected that future standardization of techniques for AFLP will also allow interlaboratory comparisons (40) .
PCR ribotyping is based on the amplification of the intergenic spacer region between the 16S and the 23S rRNA genes. Every bacterial strain contains several rRNA operons, and there is a strain-dependent variation in the size and number of the 16S-23S intergenic spacer regions. Variation in spacer length is also observed between different copies of the operons 1038 VAN (38) . Nineteen serogroups were tested and yielded different banding patterns. This method has been modified with different primers specific for C. difficile by Bidet et al. (7) . The latter method tested and discriminated 20 serogroups but was not tested for further dis- is not yet a large library, as is the case with the O'Neill method, which is used worldwide. In our study, the discriminative power of the PCR ribotyping method of O'Neill on reference strains was higher than the method of Bidet; the main difference was the ability of O'Neill's method to differentiate between strains representing serogroups A9 and A10 and A8 and S1. The toxin profile of the reference strains of the present study was identical to that of previous studies (12, 34) , except for the 3 reference strains (A9, A11, and S3). No background information was found on the toxin profile of reference strains A17 and S2. Reference strains A9 and A11 were found to be negative for the tcdA and tcdB genes, although the presence of both genes has been reported by Rupnik et al. (34) . The deletion of approximately 0.8 kb in the tcdA amplicon of the reference strain for serogroup S3 was in contrast with their results as well. In their study, strains from one serogroup sometimes belonged to two or more different toxinotypes. Our discrepant results obtained with these 3 isolates may be explained by the lack of an association of serotyping with toxinotyping. Genotyping of the reference strains showed a higher discriminatory power for AFLP than for both PCR ribotyping methods. The AFLP method was not able to differentiate reference strain A7 from A11, whereas the two PCR ribotyping methods were not able to differentiate between these and other reference strains.
The findings on the toxin profiles of the clinical isolates in our study were in agreement with previously described results (2, 3, 5, 21, 24, 26, 33) . Two French isolates, 98-15323 and 98-15845, had variant tcdA genes. Both isolates exhibited a positive result for toxin A detection by enzyme immunoassay, according to the original observation. Based on the original observation, isolate 98-15323 belonged to serogroup H and had an insertion of 200 bp in the fragment amplified with primers NK11 and NK9, whereas isolate 98-15845 was found to have a 600-bp deletion (5) . Two variants of C. difficile strain R11092 were isolated from the stored culture. The two variants differed in PCR ribotype and AFLP pattern and therefore were probably derived from a mixed infection.
For the 12 unrelated isolates, the PCR ribotyping by the Bidet method and AFLP were able to discriminate nine types, whereas the PCR ribotyping by the O'Neill method could not discriminate isolate Ned3 (serogroup K) from 98-15323 (serogroup H). PCR ribotyping is unable to discriminate between these two serogroups.
No major difference in the discriminatory power of the three genotyping techniques was observed for toxin A Ϫ /B ϩ isolates. Since a large number of these isolates were apparently clonally related, the discriminatory properties of the various typing methods could not be evaluated with these isolates. Both AFLP and PCR ribotyping by the Bidet method distinguished two types and PCR ribotyping by the O'Neill method distinguished three types. Remarkably, isolate R10542 was recognized as a unique type by PCR ribotyping by the O'Neill method but not by PCR ribotyping by the Bidet method and AFLP. Isolate R10542 was isolated from a patient in Birmingham, United Kingdom, and showed no differences to other toxin A Ϫ /B ϩ isolates in toxin profile or toxinotype (38 (35) . However, the two new toxinotypes XVI and XVII both did (36) .
A remarkably high percentage of 85% (33 of 39) of toxin A Ϫ /B ϩ C. difficile isolates showed resistance to clindamycin due to MLS resistance by the presence of the erm(B) gene. This high percentage of clindamycin resistance among toxin A Ϫ /B ϩ isolates compared to the unrelated isolates is noteworthy. Resistance to clindamycin increases the risk of C. difficile disease (11) . The MLS resistance encoded by the erm(B) gene is found to be incorporated at a site homologous to the C. difficile tcdA gene, which suggests an association between MLS resistance and pathogenicity of toxin A Ϫ /B ϩ strains (32) . Evidence is provided by Farrow et al. that the erm(B) gene resides on a transposon and is therefore likely to be transferred between C. difficile isolates (17) . The absence of this transposon could lead to clindamycin susceptibility. Another interesting explanation is the recent observation by Johnson et al. (22) , who detected two different restriction enzyme patterns (CF2 and CF4) within one PCR ribotype (017). In our study, CF2 and CF4 isolates differed in their susceptibility to clindamycin. This suggests that REA typing could discriminate between clindamycin-susceptible and -resistant strains within PCR ribotype 017.
The present study shows a better discriminatory power of reference strains for the AFLP technique than for the PCR ribotyping methods. However, for toxin A Ϫ /B ϩ C. difficile isolates, the AFLP technique has a discriminatory power similar to that of PCR ribotyping. It can be concluded that clindamycin-resistant C. difficile toxin A Ϫ /B ϩ strains of PCR ribotype 017/20, AFLP type 20, and serogroup F have a clonal worldwide spread.
